{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:33:41Z","timestamp":1790512421471,"version":"4.1.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T00:00:00Z","timestamp":1541376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16K19912"],"award-info":[{"award-number":["JP16K19912"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206643","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T13:38:20Z","timestamp":1541425100000},"page":"e0206643","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5269-0507","authenticated-orcid":true,"given":"Takashi","family":"Hirosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2113-4043","authenticated-orcid":true,"given":"Masaharu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Kanehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Ohnuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyuhiko","family":"Motoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4169-6334","authenticated-orcid":true,"given":"Takeshi","family":"Naitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin M.","family":"Selaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Unno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,11,5]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"M Carbone","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"DE Jensen","year":"1998","journal-title":"Oncogene"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10689-005-2833-4","article-title":"BAP1 and breast cancer risk","volume":"4","author":"I Coupier","year":"2005","journal-title":"Fam Cancer"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/PAS.0000000000000645","article-title":"Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma","volume":"40","author":"JA van de Nes","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","author":"M Nasu","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.eururo.2012.09.005","article-title":"Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma","volume":"63","author":"AA Hakimi","year":"2013","journal-title":"Eur Urol"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3892\/ijo.2016.3395","article-title":"Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma","volume":"48","author":"Y Togo","year":"2016","journal-title":"Int J Oncol"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ng.2813","article-title":"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas","volume":"45","author":"Y Jiao","year":"2013","journal-title":"Nat Genet"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.18632\/oncotarget.1943","article-title":"Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups","volume":"5","author":"M Simbolo","year":"2014","journal-title":"Oncotarget"},{"issue":"6009","key":"ref10","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"JW Harbour","year":"2010","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","author":"M Carbone","year":"2012","journal-title":"J Transl Med"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"MH Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gcc.22129","article-title":"Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases","volume":"53","author":"R Pilarski","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"JR Testa","year":"2011","journal-title":"Nat Genet"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"T Popova","year":"2013","journal-title":"Am J Hum Genet"},{"key":"ref16","first-page":"e194","volume":"35","author":"JA Bridgewater","year":"2016"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"A Bird","year":"2002","journal-title":"Genes Dev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"376423","DOI":"10.1155\/2015\/376423","article-title":"DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients","volume":"2015","author":"\u00c9S de Ara\u00fajo","year":"2015","journal-title":"Biomed Res Int"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4161\/epi.24552","article-title":"Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC","volume":"8","author":"I Ibragimova","year":"2013","journal-title":"Epigenetics"},{"issue":"4","key":"ref20","first-page":"574","article-title":"Establishment of a cell line (G-415) from a human gallbladder carcinoma","volume":"71","author":"S Koyama","year":"1980","journal-title":"Gan"},{"issue":"6","key":"ref21","first-page":"1251","article-title":"Establishment and characterization of a new human gallbladder carcinoma cell line (OCUG-1) producing TA-4","volume":"10","author":"N Yamada","year":"1997","journal-title":"Int J Oncol"},{"key":"ref22","unstructured":"Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 1997\u20132016. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/rsb.info.nih.gov\/ij\/\" xlink:type=\"simple\">http:\/\/rsb.info.nih.gov\/ij\/<\/ext-link>"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/ars.2013.5776","article-title":"Targeting Histone Deacetylases in Diseases: Where Are We?","volume":"23","author":"R Benedetti","year":"2015","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1358\/dot.2007.43.6.1062666","article-title":"DNA methyltransferases as targets for cancer therapy","volume":"43","author":"K Ghoshal","year":"2007","journal-title":"Drugs Today"},{"key":"ref25","article-title":"TNM classification of malignant tumours","author":"LH Sobin","year":"2009"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/1471-2407-13-371","article-title":"BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma","volume":"13","author":"KA Matatall","year":"2013","journal-title":"BMC Cancer"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/ng.2806","article-title":"Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers","volume":"45","author":"W Chan-On","year":"2013","journal-title":"Nat Genet"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"JP Thiery","year":"2009","journal-title":"Cell"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"e115472","DOI":"10.1371\/journal.pone.0115472","article-title":"Uveal melanoma cells utilize a novel route for transendothelial migration","volume":"9","author":"MD Onken","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2174\/1568009614666140804154511","article-title":"Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system","volume":"14","author":"QP Dou","year":"2014","journal-title":"Curr Cancer Drug Targets"},{"issue":"13","key":"ref31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/jnci\/djr160","article-title":"Novel proteasome inhibitors to overcome bortezomib resistance","volume":"103","author":"AM Ruschak","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clcc.2013.12.005","article-title":"A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers","volume":"13","author":"CS Denlinger","year":"2014","journal-title":"Clin Colorectal Cancer"},{"issue":"22","key":"ref33","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1002\/cncr.27586","article-title":"Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma","volume":"118","author":"B Hui","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.1381306","article-title":"Multifactorial contributions to an acute DNA damage response by BRCA1\/BARD1-containing complexes","volume":"20","author":"RA Greenberg","year":"2006","journal-title":"Genes Dev"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1158\/0008-5472.CAN-08-3355","article-title":"BRCA1-associated protein 1 interferes with BRCA1\/BARD1 RING heterodimer activity","volume":"69","author":"H Nishikawa","year":"2009","journal-title":"Cancer Res"},{"issue":"9","key":"ref36","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1373\/clinchem.2012.202390","article-title":"Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates","volume":"59","author":"H Do","year":"2013","journal-title":"Clin Chem"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"M Cigognetti","year":"2015","journal-title":"Mod Pathol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:39:52Z","timestamp":1588959592000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206643"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,5]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206643","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,5]]}}}